Tumour necrosis factor gene polymorphism in dengue infection: Association with risk of bleeding

Paediatrics and International Child Health

Volumn 33, Issue 2, 2013, Pages 97-101

  Chuansumrit, Ampaiwan ^a   Anantasit, Nattachai ^a   Sasanakul, Werasak ^a   Chaiyaratana, Wathanee ^a   Tangnararatchakit, Kanchana ^a   Butthep, Punnee ^a   Chunhakan, Sirichan ^a   Yoksan, Sutee ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Bleeding; Dengue infection; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLEEDING; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENGUE; DISEASE SEVERITY; ECCHYMOSIS; FEMALE; GENE FREQUENCY; GENETIC TRANSCRIPTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PETECHIA; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DENGUE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEMORRHAGE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877989873     PISSN: 20469047     EISSN: 20469055     Source Type: Journal    
DOI: 10.1179/2046905512Y.0000000049     Document Type: Article

References (20)

1. Rigau-Perez JG, Clark GG, Gubler DJ, Peter P, Sanders EJ, Vardam AV. Dengue and dengue hemorrhagic fever. Lancet. 1998;352:971-7.
2. Hober D, Poli L, Roblin B, Gestas P, Chungue E, Granic G, et al. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue infected patients. Am J Trop Med Hyg. 1993;48:324-31.
3. Bosch I, Xhaja K, Estevez L, Raines G, Melichar H, Warke RV, et al. Increased production of interleukin 8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol. 2002;76:5588-97.
4. Lin CF, Chiu SC, Hsiao YL, Wan SW, Lei HY, Shiau Al, et al. Expression of cytokines, chemokines and adhesion molecule during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J Immunol. 2005;174:395-403.
5. Arcardi J, Fessler MB, Abraham E. Genetic polymorphisms and sepsis. Shock. 2005;24:300-12.
6. Wjst M. Target SNP selection in complex disease association studies. BMC Bioinformatics. 2004;5:92-7.
7. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, et al. Tumor necrosis factor (TNF) gene polymorphism influences TNF-a production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol. 1998;113:401-6.
8. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff DW. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997;94:3195-9.
9. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, et al. Association of TNF2, a TNF-a promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. J Am Med Assoc. 1999;282:561-8.
10. Chuansumrit A, Tangnararatchakit K. Dengue hemorrhagic fever. In: Okpala I, Johnson C, eds. Synopsis of Hematology. CreateSpace: Charleston, SC, 2010; pp 219-35.
11. World Health Organization. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: WHO, 2009.
12. Ramathibodi Clinical Practice Guidelines. Dengue hemorrhagic fever. In: Ruangkanchanasetr S, Chongviriyaphan N, Sutabutra P, Hetrakul P, eds. Pediatrics: Guideline for Diagnosis and Treatment, vol. II. Bangkok: Bjorn Enterprises, 2004; pp 576-84.
13. World Health Organization. Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, 2nd edn. Geneva: WHO, 1997.
14. Wilson AG, de Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNFa) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1992;1:353.
15. Arslan E, Yavuz M, Dalay C. The relationship between tumor necrosis factor (TNF)-alpha and survival following granulocyte-colony stimulating factor (G-CSF) administration in burn sepsis. Burns. 2000;26:521-4.
16. Espina LM, Valero NJ, Hernandez JM, Mosquera JA. Increased apotosis and expression of tumor necrosis factor-alpha caused by infection of cultured human monocytes with dengue virus. Am J Trop Med Hyg. 2003;68:48-53.
17. O'Keefe GE, Hybki DL, Munford RS. The GRA single nucleotide polymorphism at the-308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. J Trauma. 2002;52:817-25.
18. Knight JC, Udalova I, Hill AV, Greenwood BM, Peshu N, Marsh K, et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet. 1999;22:145-50.
19. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis. 1996;174:878-80.
20. Cai B, Deitch EA, Ulloa L. Novel insights for systemic inflammation in sepsis and hemorrhage. Mediators Inflamm [Internet], 2009 [cited 2010 Apr 1]; 1-10. doi:10. 1155/2010/642462. Available from http://www.hindawi.com/journals/mi/2010/642462/